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Abstract
About four million Americans currently live with Alzheimer’s disease (AD) or related forms of dementia.
Because the disease process impairs language, insight, and judgment, family members become “caregivers.”
These caregivers, either in part or in full, often make decisions on patients’ behalf. This Issue Brief summarizes
a series of studies that describe how caregivers make decisions for AD patients, and caregiver perspectives on
the quality of life for relatives with AD.
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Editor’s Note:  About four million Americans currently live with Alzheimer’s disease
(AD) or related forms of dementia. Because the disease process impairs language,
insight, and judgment, family members become “caregivers.” These caregivers, either
in part or in full, often make decisions on patients’ behalf.  This Issue Brief
summarizes a series of studies that describe how caregivers make decisions for AD
patients, and caregiver perspectives on the quality of life for relatives with AD.
Alzheimer’s disease is a chronic, progressive, and ultimately fatal illness that is
associated with substantial physical and emotional suffering. It currently affects one
in 10 people over age 65 and nearly half of those over age 85.  Because of the
increasing elderly population, the number of Americans with AD is expected to
reach 14 million by 2050 if no cure or prevention is found.
• A person with AD lives an average of eight years after initial diagnosis and may
live as many as 20 years after the onset of symptoms.  People with AD tend to live
with their families until the most advanced stages of the disease. Spouses and
adult children—typically daughters—usually provide daily care for AD patients
not in nursing homes.
• Caregivers experience significant distress and psychological burdens in caring for
AD patients. These experiences may influence how caregivers perceive the
patient’s quality of life, and thus how they make decisions for patients.
To understand how the caregiving experience affects the decisions caregivers make,
Karlawish and colleagues interviewed 40 primary caregivers of AD patients
attending a Memory Disorders Clinic.
• Not surprisingly, from the caregiver’s perspective, lower ratings of the patient’s
quality of life were associated with lower ratings of the patient’s overall mental
health and higher ratings of the severity of the patient’s dementia.
• Nearly half of the caregivers assess the patient’s quality of life differently than they
believe the patient would.  The caregiver’s “substituted judgment” of quality of life
was lower when they perceived the patient’s mental health as poor.
Alzheimer’s disease and
other dementias have
profound impacts on
families
How caregivers rate the
quality of their relative’s
life
• The caregiver’s own experience of depression and burden was associated with
worse ratings of the patient’s quality of life.  Caregiver distress over losing control
of the patient’s behavior was most strongly associated with lower quality-of-life
judgments.
Among the same study group of 40 caregivers, Karlawish and colleagues explored
caregivers’ priorities when deciding on potential treatments for their relatives with
AD.  The interviewers described a hypothetical AD-slowing drug and asked the
caregivers to rank the importance of possible risks and benefits.
• Nearly 70% of caregivers said that they considered delaying nursing home
placement more important than extending their relative’s life by one year.
• More than half of caregivers identified a benefit more important than both
survival or delayed nursing home placement for their relative. These include
quality-of-life benefits such as maintaining memory, the ability to communicate
with and recognize family, and the ability to perform daily tasks.
• Most caregivers would accept some risk of side effects from the hypothetical drug,
ranging from mild gastrointestinal bleeding to the need for blood transfusions. In
order to slow AD progression by one year, 66% of caregivers would accept some
risk of the patient’s death.
• Caregivers who were adult children, more educated and working 20 hours or
more per week were more tolerant of risks, as were those with a family history of
the disease.
Advances in the treatment or prevention of AD depend critically on scientific
research and clinical trials. Patients with AD and their caregivers face an ethical
challenge when deciding whether to enroll in a clinical trial, because AD impairs
decision-making ability. To examine how patients and family members make this
decision, Karlawish and colleagues interviewed 22 caregivers of patients with mild to
moderate AD who were recruited for a 15-month clinical trial of a promising drug.
Of these, nine caregiver-patient pairs chose to enroll, eight declined, and five were
ineligible for the trial.
• Caregivers who enrolled were all spouses who report having made the decision
quickly, often citing the “desperation” they felt in finding help for their relative.
Caregivers who did not enroll were typically adult children who made the
decision more deliberately and focused on the hassles and burdens, such as
traveling to the study site.
• Caregivers who enrolled reported greater patient involvement in making the
decision than did the caregivers who declined to enroll.  Six of nine caregivers
who enrolled described a decision-making process that included the patient’s
preferences about enrolling.  In contrast, half of the caregivers who did not enroll
said that the patient’s role was limited to having an awareness of the trial. Five of
seven caregivers who did not enroll said that the patient had expressed a desire to
enroll.
Caregivers value AD
patient’s quality of life
more than survival or
delaying the move to a
nursing home
Caregiver burden, trust in
researchers are important
factors in deciding
whether to enroll an AD
patient into a clinical trial
POLICY IMPLICATIONS
Continued on back.
• In general, caregivers described a complex weighing of their preferences with the
patients’ preferences.  Most caregivers did not clearly distinguish risks and benefits
for themselves from those for the patient. The blending of caregiver and patient
interests points to the interdependence of the risks and benefits of research for
caregivers and patients.
• Trust was one of the key motivators to enroll in research. The caregivers cited
trust in the researchers, the clinic, the university and the pharmaceutical company
that sponsored the research. This trust helped to minimize concerns about
potential research risks and helped them cope with their desperation to find an
effective treatment.
In addition to making decisions about clinical research and treatment, caregivers
help their relatives with AD decide on a wide range of activities that dementia may
affect.  As an example, Karlawish and colleagues assessed the voting behavior of
patients with dementia in the 2000 US Presidential Election.  They surveyed 75
caregivers of patients attending an Alzheimer’s Disease Center.  All interviews were
conducted within two months of the election.
• Caregivers reported that 48 patients (64%) voted. In contrast, 70 caregivers
(93%) reported that they voted.  These figures exceed the proportion of voters
nationwide (51%) who voted in the election.
• Patients with less severe dementia, and patients with a spouse as caregiver (as
opposed to an adult child) were more likely to vote.  However, nearly one-quarter
of patients who voted had moderate or severe dementia.
• More than 90% of the patients who voted did so at a polling place; the vast
majority of them voted alone in the booth.  Patients were more likely to vote on
their own than to make their own health care decisions.
• Nearly one-quarter of the caregivers reported helping the patient vote; one
caregiver cast a vote on behalf of the patient.
• More than three-quarters of caregivers believed that they should not complete
ballots for patients unable to make voting decisions; 24% of caregivers felt that a
close family member should complete the ballot in that situation.
These studies offer an important glimpse into the perspectives of caregivers of
patients with AD, and some insights into how they make important decisions for
and with their affected relatives.
• Caregivers’ depression and burden negatively affect their perception of their
relative’s quality of life and willingness to enroll their relative in a clinical trial.
Therefore, clinicians should screen for and address caregiver depression and
burden, as well as address problematic patient behaviors that contribute to
caregiver burden.
Study assesses voting
behavior of patients with
dementia, and caregiver
assistance with voting
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• Caregiver trust in the people and institutions conducting research is crucial to
participating in AD research.  This points to the importance of human subjects
protections and other safeguards that engender and preserve trust in clinical
research.
• More research is needed to understand how persons with dementia and their
caregivers decide what activities the person can and cannot do, and how well these
decisions correspond to measures of competency.
